Results 91 to 100 of about 5,896 (149)

Hemorrhagic Complications in Patients with Atrial Fibrillation Treated with Novel Oral Anticoagulants: Results from the CRAFT Study. [PDF]

J Clin Med
Styczkiewicz M, Wawrzeńczyk M, Sukiennik A, Krzowski B, Maciejewski C, Lodziński P, Kraj L, Opolski G, Grabowski M, Balsam P, Peller M.   +10 more
europepmc   +1 more source

Cholecystectomy-Associated Postprandial Hypoglycemia. [PDF]

AACE Endocrinol Diabetes
Zhao W, Kaur J, Mirza L.
europepmc   +1 more source

Anemia, hematinic deficiencies, and gastric parietal cell antibody positivity in oral lichen planus patients with or without hyperhomocysteinemia. [PDF]

J Dent Sci
Lee YP, Jin YT, Yu-Fong Chang J, Wang YP, Sun A, Chiang CP.   +5 more
europepmc   +1 more source

Folic acid supplementation on congenital heart disease and its dual character. [PDF]

Curr Res Pharmacol Drug Discov
Wang Y, Cheng Z, He M, Gu R, Gu HF.
europepmc   +1 more source

Vitamin A Modulates AHR Signaling and Restricts Zika Virus Replication in Human Retinal Pigment Epithelial Cells: Insights from Molecular Modeling and Antiviral Assays. [PDF]

Pathogens
Marquez AB, Lanza Castronuovo PA, Barbieri CL, Castañeda Cataña MA, Sepúlveda CS, Alaimo A, Vera DMA, García CC.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Risk of Fetal Exposure to Folic Acid Antagonists

Journal of Obstetrics and Gynaecology Canada, 2004
Several folic acid antagonists are considered by the Food and Drug Administration (FDA) to be toxic or potentially toxic to fetuses, including some folic acid antagonists that were once considered safe, such as trimethoprim. Information on fetal exposure to folic acid antagonists is sparse.In this study, we conducted a thorough search of English ...
Mark Walker, Shi Wu Wen
exaly   +3 more sources

Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists

Reproductive Toxicology, 2005
Since the protective effect of folic acid (FA) on birth defects is well known, it is reasonable to assume intrauterine exposure to FA antagonists increases the risk on these defects. We have therefore performed case-control analyses to investigate the risk of intrauterine exposure to FA antagonists, using data on births from the EUROCAT Northern ...
Willemijn Meijer, Hermien De Walle, Mieke Kerstjens   +2 more
exaly   +3 more sources

Folic Acid Antagonists

Physiological Reviews, 1952
exaly   +3 more sources

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations [PDF]

British Journal of Clinical Pharmacology, 2009
Amalia Levy, Rafael Gorodischer
exaly   +2 more sources